198 related articles for article (PubMed ID: 9681489)
1. Effect of epalrestat, an aldose reductase inhibitor, on the generation of oxygen-derived free radicals in neutrophils from streptozotocin-induced diabetic rats.
Kashima K; Sato N; Sato K; Shimizu H; Mori M
Endocrinology; 1998 Aug; 139(8):3404-8. PubMed ID: 9681489
[TBL] [Abstract][Full Text] [Related]
2. Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients.
Sato N; Kashima K; Uehara Y; Ohtani K; Shimizu H; Mori M
Diabetes Care; 1997 Jun; 20(6):995-8. PubMed ID: 9167113
[TBL] [Abstract][Full Text] [Related]
3. Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients.
Sato N; Kashima K; Tanaka Y; Shimizu H; Mori M
Diabetes; 1997 Jan; 46(1):133-7. PubMed ID: 8971093
[TBL] [Abstract][Full Text] [Related]
4. Improvement of an impaired chemiluminescence response to formyl-methionyl-leucyl-phenylalanine in neutrophils from patients with non insulin dependent diabetes mellitus by recombinant human granulocyte-colony stimulating factor.
Nishizawa Y; Amakata Y; Fushiki S; Nagano F; Yoshioka F; Nosaka S; Nishizawa Y
In Vivo; 1999; 13(4):319-25. PubMed ID: 10586372
[TBL] [Abstract][Full Text] [Related]
5. Hypertonic glucose inhibits the production of oxygen-derived free radicals by rat neutrophils.
Sato N; Kashima K; Shimizu H; Uehara Y; Shimomura Y; Mori M
Life Sci; 1993; 52(18):1481-6. PubMed ID: 8387133
[TBL] [Abstract][Full Text] [Related]
6. The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic rats.
Sasaki H; Naka K; Kishi Y; Furuta M; Sanke T; Mukoyama M; Nanjo K
Exp Neurol; 1997 Aug; 146(2):466-70. PubMed ID: 9270057
[TBL] [Abstract][Full Text] [Related]
7. Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
Isogai S; Inokuchi T; Ohe K
Diabetes Res Clin Pract; 1995 Nov; 30(2):111-6. PubMed ID: 8833631
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-colony stimulating factor improves an impaired bactericidal function in neutrophils from STZ-induced diabetic rats.
Sato N; Shimizu H
Diabetes; 1993 Mar; 42(3):470-3. PubMed ID: 7679362
[TBL] [Abstract][Full Text] [Related]
9. The role of sorbitol pathway and treatment effect of aldose reductase inhibitor ONO2235 in the up-regulation of cardiac M2-muscarinic receptors in streptozotocin-induced diabetic rats.
Liu TP; Juang SW; Cheng JT; Tong YC
Neurosci Lett; 2005 Jul 22-29; 383(1-2):131-5. PubMed ID: 15936525
[TBL] [Abstract][Full Text] [Related]
10. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats.
Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T
Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532
[TBL] [Abstract][Full Text] [Related]
11. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.
Mizuno K; Kato N; Makino M; Suzuki T; Shindo M
J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874
[TBL] [Abstract][Full Text] [Related]
12. Effect of aldose reductase inhibitor on the inhibition of platelet aggregation induced by diabetic rat plasma.
Takiguchi Y; Wada K; Nakashima M
Eur J Pharmacol; 1992 May; 215(2-3):289-91. PubMed ID: 1396993
[TBL] [Abstract][Full Text] [Related]
13. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
Ishibashi Y; Matsui T; Matsumoto T; Kato H; Yamagishi S
Diab Vasc Dis Res; 2016 Jul; 13(4):312-5. PubMed ID: 27190083
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats.
Tong YC; Cheng JT
J Urol; 2007 Nov; 178(5):2203-7. PubMed ID: 17870109
[TBL] [Abstract][Full Text] [Related]
15. Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats.
Oya M; Hosokawa M; Tsukada H; Fukuda K; Nakamura H; Tsukiyama K; Nagashima K; Fujimoto S; Yamada Y; Seino Y
Diabetes Res Clin Pract; 2003 Nov; 62(2):69-77. PubMed ID: 14581143
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes.
Sobajima H; Aoki T; Sassa H; Suzuki T; Taniko K; Makino M; Mizuno K; Suzuki T
Pharmacology; 2001 May; 62(4):193-9. PubMed ID: 11359994
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy.
Ando H; Takamura T; Nagai Y; Kaneko S;
J Diabetes Complications; 2006; 20(6):367-70. PubMed ID: 17070440
[TBL] [Abstract][Full Text] [Related]
18. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
19. Effects of aldose reductase inhibition with epalrestat on diabetes-induced changes in rat isolated atria.
Booth RJ; Hodgson WC
Clin Exp Pharmacol Physiol; 1993 Apr; 20(4):207-13. PubMed ID: 8485921
[TBL] [Abstract][Full Text] [Related]
20. Effects of renal sorbitol accumulation on urinary excretion of enzymes in hyperglycaemic rats.
Ishii N; Ikenaga H; Ogawa Z; Aoki Y; Saruta T; Suga T
Ann Clin Biochem; 2001 Jul; 38(Pt 4):391-8. PubMed ID: 11471882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
